---
title: "泰诺母企 Kenvue 反驳美监管机构 反对标签怀孕期间用药涉自闭症风险"
description: "泰诺母公司 Kenvue 反驳美国监管机构对其药品标签的要求，称缺乏科学依据。Kenvue 在提交给 FDA 的文件中指出，要求更改标签的公民请愿书不合法且程序不当，并提供了压倒性证据，否认泰诺与自闭症风险之间的关联。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261925480.md"
published_at: "2025-10-20T16:12:34.000Z"
---

# 泰诺母企 Kenvue 反驳美监管机构 反对标签怀孕期间用药涉自闭症风险

> 泰诺母公司 Kenvue 反驳美国监管机构对其药品标签的要求，称缺乏科学依据。Kenvue 在提交给 FDA 的文件中指出，要求更改标签的公民请愿书不合法且程序不当，并提供了压倒性证据，否认泰诺与自闭症风险之间的关联。

止痛药及退烧药泰诺母公司 Kenvue(KVUE.US) 为其最大产品作出最详细的辩护，敦促美国监管机构拒绝有公民请愿书要求泰诺加上自闭症关联的标签。

Kenvue 於本月 17 日提交给美国食品药物管理局 (FDA) 的文件中表示，要求更改药品标签的内容缺乏科学依据，亦在法律及程序上不恰当，有压倒性证据否定该非处方止痛及退烧药与神经发展障碍之间存在任何风险的说法。

### Related Stocks

- [KVUE.US - Kenvue](https://longbridge.com/zh-CN/quote/KVUE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| EXPLAINER-Is Tylenol safe to take during pregnancy? | Consumer goods giant Kimberly-Clark plans to acquire Kenvue for over $40 billion, despite Kenvue facing lawsuits regardi | [Link](https://longbridge.com/zh-CN/news/264080046.md) |
| Kenvue Urges FDA to Reject Request for Autism Warning on Tylenol | Kenvue has urged the FDA to reject a proposal for additional warnings on acetaminophen products, following claims linkin | [Link](https://longbridge.com/zh-CN/news/261927558.md) |
| Second Pregnancy Brings New Changes To Female Brain, Study Finds | A study by researchers at Amsterdam UMC examined how first and second pregnancies affect women's brains. Following 110 w | [Link](https://longbridge.com/zh-CN/news/276474265.md) |
| Stopping Antidepressants During Pregnancy Raises Mental Health Risks, Study Finds | A study reveals that many pregnant women stop taking antidepressants, raising the risk of serious mental health emergenc | [Link](https://longbridge.com/zh-CN/news/275934391.md) |
| VA halts enforcement of new benefits rule after sparking outrage | The Department of Veterans Affairs (VA) has halted enforcement of a new rule for determining disability payments after w | [Link](https://longbridge.com/zh-CN/news/276382827.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。